Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€87.67
09.12.14
€99.00
25.03.15
6.68%
25.03.15

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€52.50
27.04.14
€120.00
23.03.15
67.05%
23.03.15

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€53.53
22.01.15
€84.00
20.03.15
1.23%
20.03.15

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€85.69
05.02.15
€100.00
18.03.15
7.04%
18.03.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€81.88
08.09.14
€95.00
28.01.15
12.25%
28.01.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Zimmer Holdings

Start price
Target price
Perf. (%)
€93.72
08.12.14
€110.00
27.01.15
7.28%
27.01.15

buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€114.22
03.12.14
€130.00
26.01.15
10.80%
26.01.15

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€86.15
28.11.14
€92.00
23.01.15
6.79%
23.01.15

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€21.90
27.10.14
€25.62
12.12.14
11.39%
12.12.14

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€80.57
10.10.14
€91.00
17.11.14
6.63%
17.11.14

buy
Aetna Inc.

Start price
Target price
Perf. (%)
€57.50
17.10.14
€70.00
07.11.14
15.84%
07.11.14

buy
Henry Schein Inc.

Start price
Target price
Perf. (%)
€46.03
06.10.14
€52.50
07.11.14
12.20%
07.11.14

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€21.31
22.04.14
€28.46
22.09.14
6.63%
22.09.14

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€72.48
22.04.14
€80.00
07.07.14
7.34%
07.07.14

buy
Cerner Corp.

Start price
Target price
Perf. (%)
€35.15
18.03.13
€38.50
01.07.13
4.80%
01.07.13

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€51.73
14.06.12
€60.00
17.07.12
8.36%
17.07.12

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€13.88
21.11.10
€22.50
23.05.11
4.14%
23.05.11

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€15.52
25.04.10
€22.29
25.10.10
-9.83%
25.10.10

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€19.18
27.05.09
€25.00
19.11.09
26.88%
19.11.09

buy
Celgene Corp.

Start price
Target price
Perf. (%)
€20.81
04.05.08
€22.00
18.09.08
6.80%
18.09.08

buy
Celgene Corp.

Start price
Target price
Perf. (%)
€25.01
23.10.07
€30.00
03.11.07
-11.26%
03.11.07

buy
Celgene Corp.

Start price
Target price
Perf. (%)
€26.00
13.10.07
€30.00
23.10.07
-5.83%
23.10.07